基本信息
views: 91
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. Yongchao Su is a Senior Principal Scientist in Pharmaceutical Sciences and Clinical Supply, Merck & Co, Inc. He teaches as an Adjunct Associate Professor in the College of Pharmacy at the University of Texas at Austin and Purdue University, and Professor of Practice in School of Pharmacy at University of Connecticut. Yongchao received his Ph.D. of Chemistry at Iowa State University in 2011 and then a postdoctoral training at MIT till 2014. His current research aims to understand molecular mechanisms of drug delivery, stability, and quality. He has published over 120 peer-reviewed articles and many patents on chemical and biological therapeutics. In 2022, he was elected a Fellow of the Royal Society of Chemistry (FRSC).
Research Interests
Papers共 156 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Ryan Schroder, Phillip J. Dorsey, Joe Vanderburgh,Wei Xu,Suzanne M. D'Addio,Lee Klein,Marian Gindy,Yongchao Su
ANALYTICAL CHEMISTRYno. 6 (2024): 2464-2473
Patrick Larpent,Lorenzo Codan, Jameson R Bothe,Luca Iuzzolino, Suzette Pabit, Sudipta Gupta,Thierry Fischmann,Yongchao Su,Paul Reichert,Dirk Stueber,Aaron Cote
Molecular pharmaceutics (2024)
The journal of physical chemistry lettersno. 21 (2024): 5714-5720
Jing Song,Marc Taraban,Y. Bruce Yu, Lynn Lu, Pallavi Guha Biswas,Wei Xu,Hanmi Xi,Akhilesh Bhambhani,Guangli Hu,Yongchao Su
MABSno. 1 (2024)
Journal of pharmaceutical and biomedical analysis (2024): 116228-116228
Molecular Pharmaceutics (2024)
Jing Song,Marc Taraban,Y. Bruce Yu, Lynn Lu, Pallavi Guha Biswas,Wei Xu,Hanmi Xi,Akhilesh Bhambhani,Guangli Hu,Yongchao Su
MABSno. 1 (2024): 2304624-2304624
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn